• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC141400
Device Problems Break (1069); Premature Activation (1484); Failure to Advance (2524)
Patient Problem No Information (3190)
Event Date 05/27/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, the patient was implanted with a system of gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.During the procedure, a trunk-ipsilateral component was deployed as planned.However, the physician encountered difficulty cannulating the contralateral gate.According to the report the patient¿s anatomy was extremely tortuous, and the sheath could not be advanced to the level of the contralateral gate.During the attempt to cannulate the gate, the contralateral leg component (pxc141400/12426768) reportedly had become caught on the distal end of the sheath, causing the deployment string to break and the device to prematurely deploy in the left common iliac artery.The left hypogastric artery was unintentionally covered by the device.The physician was able to implant an additional contralateral limb to bridge the space between the contralateral gate and the prematurely deployed device.The procedure was concluded without any further reported complications, and the patient tolerated the procedure.
 
Manufacturer Narrative
A review of the manufacturing paperwork for the devices verified that the lots met all pre-release specifications.Per the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and / or require intervention include, but are not limited to improper endoprosthesis component placement and occlusion of native vessel.The gore® excluder® aaa endoprosthesis ifu states ¿do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
damon jackson
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3869706
MDR Text Key4457693
Report Number2953161-2014-00071
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/27/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2017
Device Catalogue NumberPXC141400
Device Lot Number12426768
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/12/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/07/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-